Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-09

Clinical Trial Update: The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization

View source ↗

Summary

A completed clinical trial suggests that the size of a pelvic hematoma may predict the need for pelvic angioembolization in patients with pelvic fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asan Medical Center | Conditions: Multiple Pelvic Fractures | Status: COMPLETED